Akebia Therapeutics | AKBA - Gross Profit On Sales


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview

Akebia Therapeutics

Akebia Therapeutics reported $29.09M in Gross Profit on Sales for its fiscal quarter ending in March of 2023.


Gross Profit On Sales Change
Acadia Pharmaceuticals ACAD:US USD 116.8M 17.28M
Agios Pharmaceuticals AGIO:US USD 5.06M 1.16M
Akebia Therapeutics AKBA:US USD 29.09M 37.35M
Alnylam Pharmaceuticals ALNY:US USD 264.42M 19.35M
Amgen AMGN:US USD 4.42B 669M
Ardelyx ARDX:US USD 9.83M 31.18M
Astellas Pharma 4503:JP JPY 291.97B 35.78B
AstraZeneca AZN:LN USD 8.83B 130M
Bayer BAYN:GR EUR 8.66B 1.42B
BioMarin Pharmaceutical BMRN:US USD 469.87M 59.62M
Exelixis EXEL:US USD 394.47M 13.52M
Fresenius Medical Care FME:GR EUR 1.15B 198.52M
GlaxoSmithKline GSK:LN GBP 5.05B 151M
Intercept Pharmaceuticals ICPT:US USD 67.74M 9.46M
Ionis Pharmaceuticals IONS:US USD 129.18M 19.02M
J&J JNJ:US USD 16.35B 356M
Karyopharm Therapeutics KPTI:US USD 37.35M 5.64M
Moderna Inc MRNA:US USD 1.07B 2.1B
Nektar Therapeutics NKTR:US USD 14.53M 1.26M
PTC Therapeutics PTCT:US USD 206.24M 49.72M
Regeneron Pharmaceuticals REGN:US USD 2.7B 169.2M
Roche Holding ROG:VX CHF 22.04B 696M
Sarepta Therapeutics SRPT:US USD 218.48M 9.14M
Seattle Genetics SGEN:US USD 407.94M 12M